Twisted web of lies in Maryanne Godboldo Case: Big Pharma, multiple agencies, judge, DHS all profit from child abduction

There is a good chance you have heard the story of Maryanne Godboldo and how armed government agents broke down her door and attempted to kidnap her 13-year-old daughter Ariana to turn over to CPS because she refused to medicate her with a potentially dangerous and mind-altering anti-psychotic drug Risperdal (http://www.naturalnews.com/032191_C…). Maryanne had been using holistic remedies for her daughter instead, such as dance therapy.

The Detroit mother is now currently going through a criminal and custody trial because of this incident, and a variety of revealing and disturbing information is starting to come out about the involvement of Big Pharma and other parties in the twisted web of lies the case is wrapped in.

The jury presiding over the hearing was convinced to believe that Maryanne’s refusal to give her daughter the controversial drug, supposedly used to “treat” ADHD, represented a form of parental neglect. Thanks to the Voice of Detroit (VOD), it is now coming to light that the New Oakland Child-Adolescent & Family Center – a private facility which reported Maryanne to CPS for taking her daughter off the drug — has paid connections with Big Pharma since at least 2004.

Bad Side-Effects Ahead For Pharma?

In 2006, The New York Review of Books reported that four-year-old Rebecca Riley died of the effects of two prescription drugs—Clonidine and Depakote.

These medications, along with Seroquel, were prescribed for Rebecca after she was diagnosed, at the age of two, with attention deficit hyperactivity disorder (ADHD) and bipolar disorder. The three drugs are not approved by the Food and Drug Administration (FDA) for treatment of ADHD or long-term treatment of bipolar disorder, nor are they approved for children as young as Rebecca.

The New York Review of Books‘ recent two-part article (1) by Marcia Angell on the treatment of mental illness with psychoactive drugs (those that affect the mental state) addresses an issue that may one day prove very important to investors in pharmaceutical stocks. (All statistics and quotations herein are drawn from Dr. Angell’s article.) It is not illegal for a doctor to prescribe a drug off-label, that is, for a non-FDA-approved use, but a drug marketer cannot lawfully encourage a doctor to do so. The profits in psychoactive drugs, however, make it tempting to flout the law. In the past four years, AstraZeneca (AZN), Pfizer (PFE), Eli Lilly (LLY), Bristol-Myers Squibb (BMY) and Forest Labs (FRX) have all settled federal charges of marketing psychoactive drugs off-label, at a cost running into hundreds of millions.

Military’s drug policy threatens troops’ health, doctors say

Army leaders are increasingly concerned about the growing use and abuse of prescription drugs by soldiers, but a Nextgov investigation shows a U.S. Central Command policy that allows troops a 90- or 180-day supply of highly addictive psychotropic drugs before they deploy to combat contributes to the problem.

Drug formulary includes drugs like Valium and Xanax, used to treat depression, as well as the antipsychotic Seroquel, originally developed to treat schizophrenia, bipolar disorders, mania and depression.

Dr. Grace Jackson, a former Navy psychiatrist, told Nextgov she resigned her commission in 2002 “out of conscience, because I did not want to be a pill pusher.”